Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
作者信息
Garzón-Olivares Carmen Doris, Grillo-Ardila Carlos Fernando, Amaya-Guío Jairo
机构信息
Universidad Nacional de Colombia, Bogotá (Colombia)..
出版信息
Rev Colomb Obstet Ginecol. 2023 Mar 30;74(1):92-94. doi: 10.18597/rcog.4015.
Abstract
摘要
相似文献
1
Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
Rev Colomb Obstet Ginecol. 2023 Mar 30;74(1):92-94. doi: 10.18597/rcog.4015.
2
Comments on the article, “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
Rev Colomb Obstet Ginecol. 2023 Mar 30;74(1):90-91. doi: 10.18597/rcog.3970.
3
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280.
4
HIV-Infected Patients With Anal Cancer Precursors: Clinicopathological Characteristics and Human Papillomavirus Subtype Distribution.
Dis Colon Rectum. 2020 Jul;63(7):890-896. doi: 10.1097/DCR.0000000000001671.
5
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
6
Authors' reply to Vorsters and colleagues.
BMJ. 2014 Oct 15;349:g6253. doi: 10.1136/bmj.g6253.
7
Microbiological diagnosis of human papilloma virus infection.
Enferm Infecc Microbiol Clin. 2017 Nov;35(9):593-602. doi: 10.1016/j.eimc.2016.05.008. Epub 2016 Jun 25.
8
[Prevalencia y genotipos del virus del papiloma humano en muestras de tejido laríngeo de pacientes con cáncer de laringe del noreste de México].
Cir Cir. 2018;86(6):499-507. doi: 10.24875/CIRU.18000297.
9
2013 statement on human papillomavirus [corrected] test utilization.
Acta Cytol. 2014;58(2):113-6. doi: 10.1159/000358795. Epub 2014 Feb 12.
10
[Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 3):e1-43.
本文引用的文献
1
A systematic review of economic evaluations of cervical cancer screening methods.
Syst Rev. 2022 Aug 9;11(1):162. doi: 10.1186/s13643-022-02017-z.
2
Cervical Cancer Screening: Is the Age Group 30-65 Years Optimum for Screening in Low-Resource Settings?
J Obstet Gynaecol India. 2021 Oct;71(5):530-536. doi: 10.1007/s13224-021-01479-w. Epub 2021 May 1.
3
Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
PLoS One. 2020 Sep 30;15(9):e0239611. doi: 10.1371/journal.pone.0239611. eCollection 2020.
4
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
Br J Cancer. 2020 May;122(11):1715-1723. doi: 10.1038/s41416-020-0790-1. Epub 2020 Apr 3.
5
Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
BMJ Open. 2018 Jun 12;8(6):e020484. doi: 10.1136/bmjopen-2017-020484.
6
Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
BMJ Open. 2017 Jun 15;7(6):e015048. doi: 10.1136/bmjopen-2016-015048.
7
Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Int J Cancer. 2017 Aug 1;141(3):437-446. doi: 10.1002/ijc.30695. Epub 2017 Apr 3.
8
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3.
9
Screening for cervical cancer: a systematic review and meta-analysis.
Syst Rev. 2013 May 24;2:35. doi: 10.1186/2046-4053-2-35.
Zotero 插件